Santa Rosa, Calif.-based Osseon Therapeutics appointed Gary Hogman as regional sales director.
NuVasive named Gregory Lucier to its board of directors.
Carlsbad, Calif.-based Aurora Spine appointed Eric Fronk as CFO.
IlluminOss Medical, a privately held, commercial stage medical device company, appointed Frederick Tobia as vice president of regulatory and clinical affairs.
Former Group Finance Director Steve Barrow stepped down from the Victrex board of directors after 19 years, effective Jan. 31, 2014. He will be succeeded by Louisa Burdett. Victrex is the parent company of Invibio Biomaterial Solutions.
Smith & Nephew appointed Roberto Quarta as a non-executive director and chairman-elect.
Histogenics, a Waltham, Mass.-based biologics company, has announced the appointment of Nancy Lynch, MD, as its chief medical officer.
More Articles on Devices:
Net Losses to Go Around: 11 Recent Spine Device Company Financial Reports
Smith & Nephew Experiences Sustainable Growth
Hospital in Southeastern US Purchases Renaissance Spine System
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
